Safety, Tolerability, and Pharmacokinetic Study of Methylene Blue Following a 1 mg/kg Intravenous Dose in Healthy Adults

Clinical trial NCT02478281 · COMPLETED

Trial details

NCT number: NCT02478281
Sponsor: American Regent, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Methemoglobinemia Congenital Methemoglobinemia

Start date: 2012-10-01
Primary completion: 2012-10-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.